Amador Bioscience
Kempische Steenweg 309, Corda Campus, Gebouw 2, bus 1.05
3500 Hasselt
BE
Amador Bioscience
Foundation date
11/01/2022
Sector
#Biotechnology / R&D ServicesSubsector
Amador Bioscience provides global translational research and clinical development solutions. With established sites in the United States, Europe, and China, Amador confidently meets international clinical trial quality and compliance standards. We enhance the success rate of new drugs in any regulatory setting and take innovative drug development projects from pre-clinical research and development to market approval.
Upcoming events
All events-
2206 '23
Translational Research in Crops
Event by: VIB -
0310 '23
-
1810 '23
EMDS2023@VIB
Event by: VIB
Latest news
More news-
SANTERO announces a €8 million Series A funding round led by Newton Biocapital to develop novel antibiotics in the fight against antimicrobial resistance
14 hours ago
Read more
-
HERAN Partners co-leads the GBP 6,5m financing round of Hypervision Surgical to support the further development and commercial roll-out of their Hyperspectral Imaging platform
Tuesday June 6th 2023
Read more
-
ANeuroTech receives IND approval from the FDA for pivotal Phase IIIB trial of adjunctive anti-depression drug, ANT-01
Monday June 5th 2023
Read more